The main objective of this study is to describe the demographic, clinical, and biological characteristics of patients with STEMI admitted to a representative setting of cardiology centres in ESC-member countries in Europe. Other objectives are to assess management patterns and in particular the current use of reperfusion therapies and to evaluate how recommendations of most recent STEMI European guidelines regarding reperfusion therapies and adjunctive pharmacological and non-pharmacological treatments are adopted in clinical practice and how their application can impact on patients’ outcomes. Information on the reasons why evidencebased treatments are not utilized will be collected. An interesting objective will be to evaluate the organization of STEMI management across Europe and Mediterranean countries specifically regarding the diagnostic and admission process and treatment pathways. The registry will validate the prognostic predictors of inhospital and 1-year outcomes. In particular, patients with Cardiopulmonary resuscitation and/or cardiogenic shock, who still present a high mortality rate despite reperfusion therapy. A 1-year follow-up will be performed to assess long-term event rate and adherence to secondary prevention measures.
The European society of cardiology ACCA-EAPCI registry on ST elevation myocardial infarction: A new Registry to evaluate the treatment of STEMI across Europe and the Mediterranean countries is discussed
Ferrari, Roberto;Maggioni, Aldo P.;
2017
Abstract
The main objective of this study is to describe the demographic, clinical, and biological characteristics of patients with STEMI admitted to a representative setting of cardiology centres in ESC-member countries in Europe. Other objectives are to assess management patterns and in particular the current use of reperfusion therapies and to evaluate how recommendations of most recent STEMI European guidelines regarding reperfusion therapies and adjunctive pharmacological and non-pharmacological treatments are adopted in clinical practice and how their application can impact on patients’ outcomes. Information on the reasons why evidencebased treatments are not utilized will be collected. An interesting objective will be to evaluate the organization of STEMI management across Europe and Mediterranean countries specifically regarding the diagnostic and admission process and treatment pathways. The registry will validate the prognostic predictors of inhospital and 1-year outcomes. In particular, patients with Cardiopulmonary resuscitation and/or cardiogenic shock, who still present a high mortality rate despite reperfusion therapy. A 1-year follow-up will be performed to assess long-term event rate and adherence to secondary prevention measures.I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
